PSS43 - DUPILUMAB IMPROVES ABSENTEEISM IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS COMPARED WITH PLACEBO IN PHASE 3 LIBERTY AD SOLO STUDIES
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2543
https://www.valueinhealthjournal.com/article/S1098-3015(18)35845-5/fulltext
Section Title :
Section Order :
1898
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35845-5&doi=10.1016/j.jval.2018.09.2543